🇺🇸 FDA
Patent

US 9695229

Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules

granted A61KA61K31/519A61K38/57

Quick answer

US patent 9695229 (Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/519, A61K38/57, A61K45/06, A61P